Log In
Print
BCIQ
Print
Print this Print this
 

TAS-116

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionOral heat shock protein 90 (Hsp90) alpha/beta selective inhibitor
Molecular Target Heat shock protein 90 (Hsp90)
Mechanism of ActionHsp90 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today